- Home
- NKTR vs MQT Comparison
NKTR vs MQT Comparison
Compare NKTR & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- MQT
- Stock Information
- Founded
- NKTR 1990
- MQT 1992
- Country
- NKTR United States
- MQT United States
- Employees
- NKTR N/A
- MQT N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- MQT Investment Bankers/Brokers/Service
- Sector
- NKTR Health Care
- MQT Finance
- Exchange
- NKTR Nasdaq
- MQT Nasdaq
- Market Cap
- NKTR 558.0M
- MQT 218.4M
- IPO Year
- NKTR 1994
- MQT N/A
- Fundamental
- Price
- NKTR $49.89
- MQT $10.15
- Analyst Decision
- NKTR Strong Buy
- MQT
- Analyst Count
- NKTR 6
- MQT 0
- Target Price
- NKTR $81.67
- MQT N/A
- AVG Volume (30 Days)
- NKTR 1.1M
- MQT 52.5K
- Earning Date
- NKTR 11-06-2025
- MQT 01-01-0001
- Dividend Yield
- NKTR N/A
- MQT 4.60%
- EPS Growth
- NKTR N/A
- MQT N/A
- EPS
- NKTR N/A
- MQT N/A
- Revenue
- NKTR $74,934,000.00
- MQT N/A
- Revenue This Year
- NKTR N/A
- MQT N/A
- Revenue Next Year
- NKTR N/A
- MQT N/A
- P/E Ratio
- NKTR N/A
- MQT N/A
- Revenue Growth
- NKTR N/A
- MQT N/A
- 52 Week Low
- NKTR $6.48
- MQT $8.59
- 52 Week High
- NKTR $50.53
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- NKTR 85.11
- MQT 81.42
- Support Level
- NKTR $42.12
- MQT $9.47
- Resistance Level
- NKTR $50.53
- MQT $10.15
- Average True Range (ATR)
- NKTR 3.36
- MQT 0.08
- MACD
- NKTR 1.49
- MQT 0.06
- Stochastic Oscillator
- NKTR 97.18
- MQT 97.23
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.